ANTHEMBSEAnthem Biosciences LtdHighPositive
Announced Tue, 19 May · 19:49 IST

Record date for final dividend

Pat Growth 25pctResults View source PDF

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹780.00
prior close
₹801.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+1.0+0.8+0.4-1.3-0.5-2.2-1.3-3.0-3.8+0.0-1.7+1.2
Up moveDown movePending
AI summary

Anthem Biosciences Board approved FY2026 results with standalone revenue of Rs 2,089 crore (up 13.5%) and consolidated revenue of Rs 2,120 crore (up 15%). Standalone PAT grew 27% to Rs 570 crore while consolidated PAT grew 31% to Rs 592 crore. The Board recommended a final dividend of Rs 2 per share (100% payout on face value), with record date June 26, 2026. The company also allotted 14.81 lakh equity shares under ESOP 2024. Auditors issued unmodified opinion on both standalone and consolidated financials.

Likely market impact

Strong financial performance with PAT growth exceeding 25% signals positive sentiment for shareholders. The dividend recommendation provides immediate return opportunity with record date set for late June.